The Broad Global Health Initiative brings together local and international Broad Insitute collaborators to share their experiences of COVID-19 with the aim of spotlighting the impact of the pandemic around the world. Speakers provide perspectives on their communities’ response to the outbreak, discuss implications for their research or practice, and share lessons learned.
|
Carlos Aguilar-Salinas, M.D., Ph.D.
Director of Nutrition, National Institute of Medical Sciences and Nutrition Salvador Zubirán Mexico City, Mexico
Teresa Tusié-Luna, M.D., Ph.D.
Head of Molecular Biology and Genomic Medicine, National Institute of Medical Sciences and Nutrition Salvador Zubirán & National Autonomous University of Mexico Mexico City, Mexico
Alicia Huerta-Chagoya, Ph.D.
Professor of Genetics, National Autonomous University of Mexico Researcher, National Institute of Medical Sciences and Nutrition Salvador Zubirán Mexico City, Mexico |
COVID-19 in Mexico and the impact of pre-existing conditions:
Broad collaborators share perspectives on the global health impact of COVID-19 in Mexico.
|
||
|
Brought to you by the Broad Global Health Initiative and co-hosted with LatinX@Broad
|
|||
|
Nancy Krieger
Professor of Social Epidemiology and Director, Interdisciplinary Concentration on Women, Gender, and Health, Harvard T.H. Chan School of Public Health
Adrianne Gladden-Young
Senior Viral Genomics Researcher, Sabeti Lab at the Broad Institute, Author, "Give Black Scientists a Place in This Fight", The Atlantic
Alister Martin
Emergency Medical Specialist, Massachusetts General Hospital, MGH Center for Social Justice and Health Equity at Harvard Medical School |
Health disparities impacting Black communities in the Boston area:
Local academic, medical, and community leaders share data and perspectives on the racial disparities of the COVID-19 experience in the Boston area.
|
||
|
Brought to you by the Broad Global Health Initiative and co-hosted with Shades@Broad
|
|||
|
Fernando Bozza, M.D., Ph.D.
Senior Scientist, Oswaldo Cruz Foundation Head of Critical Care, National Institute of Infectious Diseases Rio de Janeiro, Brazil
Socrates Herrera, M.D.
Director, Caucaseco Scientific Research Center Cali, Colombia
Marcia Castro, Ph.D.
Andelot Professor of Demography, Chair, Department of Global Health and Population, Harvard T.H. Chan School of Public Health Boston, USA |
Social, political, and public health factors fueling the COVID-19 crisis in South America:
Friends and collaborators of Broad global health science, who are leading COVID-19 response efforts in their home countries, speak about the global health impact of COVID-19 in Brazil and Colombia.
|
||
|
Brought to you by the Broad Global Health Initiative and co-hosted with LatinX@Broad
|
|||
|
Sun Jae Jung, M.D., Ph.D.
Assistant Professor of Psychiatric Epidemiology, Yonsei University College of Medicine Seoul, South Korea
Xiancang Ma, M.D.
Professor of Psychiatry and Vice President, The First Affiliated Hospital of Xi’an Jiaotong University Xi’an, China |
Perspectives on the global health impact of COVID-19 and finding a “new normal” in South Korea and China:
Partners from Broad’s Stanley Global efforts speak about tackling COVID-19 on the frontlines, the mental health burden of the pandemic in their communities, and lessons we can learn from their experience in the post-peak period.
|
||
|
Brought to you by the Broad Global Health Initiative
|
|||
|
Dyann F. Wirth, Ph.D.
Chair, World Health Organization Malaria Program Action Committee, Richard Pearson Strong Professor and Chair, Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Faculty Chair, Harvard Integrated Life Sciences Program, Harvard Graduate School of Arts and Sciences Senior Associate Member, Broad Institute of MIT and Harvard |
Pandemic’s effects on endemic infectious diseases, like malaria, and the use of chloroquine, formerly best known as a malaria drug:
Dyann Wirth, a leader of the World Health Organization’s Malaria Program Advisory Committee, discusses how the WHO is addressing COVID-19 and its impact on the burden and control of endemic infectious diseases, chloroquine as a potential COVID-19 treatment, and the impact on its use and availability as a frontline malaria therapy.
|
||
|
Brought to you by the Broad Global Health Initiative
|
|||
